Key Laboratory of Drug Monitoring and Control, Drug Intelligence and Forensic Center, Ministry of Public Security, P.R.C., Beijing, China.
China Pharmaceutical University, Nanjing, China.
Drug Test Anal. 2023 Jan;15(1):47-57. doi: 10.1002/dta.3358. Epub 2022 Sep 7.
In this study, the analytical characterization of three cathinones and one N-pyrrolidinyl-substituted amphetamine derivative is described: 1-([3,4-methylenedioxyphenyl])-2-(propylamino)butan-1-one (N-propyl norbutylone 1), 1-([3,4-methylenedioxyphenyl])-2-(butylamino)butan-1-one (N-butyl norbutylone 2), 2-(benzylamino)-1-phenylheptan-1-one (N-benzyl norheptedrone 3), and 1-(1-[3,4-dimethoxyphenyl]propan-2-yl)pyrrolidine (N-pyrrolidinyl-3,4-DMA 4). The identification was based on ultra-high-performance liquid chromatography-quadrupole time-of-flight-mass spectrometry (UHPLC-QTOF-MS), gas chromatography-orbitrap MS (GC-Orbitrap-MS), nuclear magnetic resonance spectroscopy (NMR), and Fourier transform infrared (FT-IR). GC-Orbitrap-MS, with higher mass accuracy, benefit more on the accurate structure elucidation of product ions compared with the low-resolution GC-MS. The collision-induced dissociation (CID) and electron ionization (EI) pathways of these compounds were examined to assist forensic laboratories in elucidating the structure of new psychoactive substances (NPS) with similar structure in their case work. In addition, electron activated dissociation (EAD) was applied to analyze N-benzyl norheptedrone, which showed only one product ion in the CID mode. The result showed that for compound with limited product ions in the CID mode, the EAD mode can give more complementary information for structure elucidation. In addition, quantitative NMR (qNMR) was applied for the quantification of four powdered/crystal and two herbal blend seized samples. To our knowledge, no analytical data about the compounds 3 and 4 have appeared until now, making this the first report on these compounds.
在这项研究中,描述了三种卡西酮和一种 N-吡咯烷基取代苯丙胺衍生物的分析特性:1-([3,4-亚甲二氧基苯基])-2-(丙基氨基)丁-1-酮(N-丙基-正丁基酮 1)、1-([3,4-亚甲二氧基苯基])-2-(丁基氨基)丁-1-酮(N-丁基-正丁基酮 2)、2-(苄基氨基)-1-苯基庚烷-1-酮(N-苄基-正庚德酮 3)和 1-(1-[3,4-二甲氧基苯基]丙-2-基)吡咯烷(N-吡咯烷基-3,4-DMA 4)。鉴定基于超高效液相色谱-四极杆飞行时间质谱(UHPLC-QTOF-MS)、气相色谱-轨道阱质谱(GC-Orbitrap-MS)、核磁共振波谱(NMR)和傅里叶变换红外(FT-IR)。与低分辨率 GC-MS 相比,具有更高质量精度的 GC-Orbitrap-MS 更有利于准确解析产物离子的结构。研究了这些化合物的碰撞诱导解离(CID)和电子电离(EI)途径,以帮助法医实验室在案件工作中阐明具有相似结构的新型精神活性物质(NPS)的结构。此外,还应用电子激活解离(EAD)来分析 N-苄基-正庚德酮,其在 CID 模式下仅显示一个产物离子。结果表明,对于在 CID 模式下产物离子有限的化合物,EAD 模式可以为结构解析提供更多补充信息。此外,还应用定量 NMR(qNMR)对四个粉末/晶体和两个草药混合物缴获样品进行定量。据我们所知,目前还没有关于化合物 3 和 4 的分析数据,这使得这是关于这些化合物的首次报告。